Sayer, Robyn A <br/><br/>
High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer.  [electronic resource] 

 -  Gynecologic oncology  Feb 2005 
 - 355-61 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0090-8258 
<br/><br/><label>Standard No.: </label>10.1016/j.ygyno.2004.10.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cystadenocarcinoma, Serous--genetics<br/>Female<br/>Gene Expression<br/>Humans<br/>Insulin-Like Growth Factor II--biosynthesis<br/>Ovarian Neoplasms--genetics<br/>Predictive Value of Tests<br/>Prognosis<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Survival Rate